Published in Clinical Oncology Week, August 17th, 2009
"Limited information is available on the use of herceptin in pregnancy. This case is a twin pregnancy exposed to herceptin until 23 weeks' gestation," wrote J.M.A. Beale and colleagues.
The researchers concluded: "One twin had chronic renal failure develop, whereas the other twin did not.."
Beale and colleagues published their study in American Journal of Obstetrics and Gynecology (Herceptin (Trastuzumab) therapy in a twin pregnancy with associated oligohydramnios. American...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Oncology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.